On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Epivax Inc's own share of each project, not the project's full budget.
- Horizon 2020€806k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- INDIGOPartner
Effective and Affordable Flu Vaccines for the World
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€806ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Universiteit GentBelgium · 1 shared project
- Universiteit van AmsterdamNetherlands · 1 shared project
- Stichting Amsterdam UmcNetherlands · 1 shared project
- Expres2ion Biotechnologies ApSDenmark · 1 shared project
- Litevax BVNetherlands · 1 shared project
- Council of Scientific and Industrial ResearchIndia · 1 shared project
- Vismederi SRLItaly · 1 shared project
- CellvaxFrance · 1 shared project
- Viroclinics Biosciences BVNetherlands · 1 shared project
- Gennova Biopharmaceuticals LimitedIndia · 1 shared project
- CBCI Society for Medical EducationIndia · 1 shared project
- StanipharmFrance · 1 shared project
- Christian Medical College VelloreIndia · 1 shared project
- Translational Health Science and Technology InstituteIndia · 1 shared project
- Clinical Development Services AgencyIndia · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- immunology
- influenza
- pandemics
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.